The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma. [electronic resource]
Producer: 20190828Description: 5387-5396 p. digitalISSN:- 1543-8392
- Acetanilides -- pharmacokinetics
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Cell Line, Tumor
- Drug Synergism
- Heterocyclic Compounds, 3-Ring -- pharmacokinetics
- Humans
- Mice
- Multiple Myeloma -- drug therapy
- Prospective Studies
- Proteins -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.